GenTeal Tears, 10g recall — Alcon Research LLC (Class II)
Alcon Research LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling GenTeal Tears, 10g — a Class II recall, initiated 2026-04-21 and posted to the FDA enforcement report on 2026-05-06, under recall number D-0492-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.”. From the product description, the form is gel, the strength given is 10g and the package is described as 0.34 Fl oz. 1 National Drug Code number is printed in the record: 0065-8064-01. Distribution is recorded as “Nationwide within the United States” — Nationwide (US), with the recalling firm on record in TX, United States. The FDA files it under event ID 98815 together with 1 other recall number, all listed and linked below. Within that event this is the package 0.34 Fl oz, ndc 0065-8064-01 and product named GenTeal Tears configuration; the sibling records differ on package, ndc and product named and match on everything else the source states. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0492-2026 |
|---|---|
| FDA event ID | 98815 (2 recall numbers) |
| Classification | Class II (intermediate regulatory tier) |
| Status | Ongoing |
| Recalling firm | Alcon Research LLC |
| Recall initiated | 2026-04-21 |
| Reported by FDA | 2026-05-06 |
| Report lag | 15 days from initiation to report |
| Distribution | Nationwide within the United States — Nationwide (US) |
| Firm location on record | TX, United States |
| Product description (source) | GenTeal Tears, Lubricant Eye Gel, Sterile, 10g (0.34 Fl oz), Distributed by: Alcon Laboratories, Inc., Fort Worth, Texas 76134, USA, NDC: 0065-8064-01. |
Reason reported by FDA
Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.
17 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
5 identifying values matched by exact pattern in the 22-word product description above; each is a literal substring of it.
| Product named | GenTeal Tears |
|---|---|
| Form | Gel |
| Strength | 10g |
| Package | 0.34 Fl oz |
| NDC | 0065-8064-01 |
| Distributed by | Alcon Laboratories, Inc. |
Which configuration this record is
2 recall numbers share event 98815. They differ on package, ndc and product named and agree on everything else the source states, so those are the values to check a package against.
| Attribute | This record (D-0492-2026) | D-0491-2026 |
|---|---|---|
| Package | 0.34 Fl oz | — |
| NDC | 0065-8064-01 | 0065-0474-01 |
| Product named | GenTeal Tears | Systane |
Shared across all 2 records under this event: strength 10g; form Gel; fda tier Class II; recalling firm Alcon Research LLC; the same reason text; initiated 2026-04-21; reported 2026-05-06.
Event context: 2 recall numbers under event 98815
One enforcement action, 2 recall numbers: the FDA filed 1 further configuration of this action under event 98815. Each keeps its own recall number and dates.
| Recall record | Recall number | FDA tier | Strength / form | NDC | Reported |
|---|---|---|---|---|---|
| Systane, 10g | D-0491-2026 | Class II | 10g · Gel | 0065-0474-01 | 2026-05-06 |
Reported in the same month (2026-05)
48 enforcement reports carry a report date in 2026-05; these 8 are the Class II ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Optase Dry Eye Intense Drops (Glycerin 0.2%) | D-0499-2026 | Scope Health | Class II | 2026-05-06 |
| iVIZIA, 0.5% | D-0500-2026 | Thea Pharma, Inc. | Class II | 2026-05-06 |
| Similasan, 0.5% | D-0501-2026 | Thea Pharma, Inc. | Class II | 2026-05-06 |
| Phenylephrine Hydrochloride Injectable Solution, 40mg | D-0502-2026 | Wells Pharma OF Houston LLC | Class II | 2026-05-06 |
| fentaNYL Citrate Injectable Solution, 1000 mcg/100 mL | D-0503-2026 | Wells Pharma OF Houston LLC | Class II | 2026-05-06 |
| fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride | D-0504-2026 | Wells Pharma OF Houston LLC | Class II | 2026-05-06 |
| fentaNYL Citrate Injectable Solution, 1250 mcg/25mL | D-0505-2026 | Wells Pharma OF Houston LLC | Class II | 2026-05-06 |
| fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride | D-0506-2026 | Wells Pharma OF Houston LLC | Class II | 2026-05-06 |
Nearest Class II recalls by date
213 of 250 indexed records share the Class II tier; the 7 nearest to 2026-05-06 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Ketamine Hydrochloride Injectable Solution, 50mg/ml | D-0507-2026 | Wells Pharma OF Houston LLC | 50mg/ml · Solution | 2026-05-06 |
| fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride | D-0508-2026 | Wells Pharma OF Houston LLC | 0.9% · Solution | 2026-05-06 |
| Alendronate Sodium Oral Solution, 70 mg/75 mL | D-0526-2026 | Hikma Pharmaceuticals Usa Inc | 70 mg/75 mL · Oral Solution | 2026-05-06 |
| Furosemide Tablets, 80 mg | D-0486-2026 | Leading Pharma, LLC | 80 mg · Tablets | 2026-04-29 |
| FRESHKOTE LUBRICANT EYEDROPS, 10mL | D-0489-2026 | Harrow Eye LLC | 10mL | 2026-04-29 |
| Omega-3-Acid, 1 gram | D-0493-2026 | The Harvard Drug Group LLC | 1 gram · Capsules | 2026-04-29 |
| DEXTROSE INJECTION USP, 70% | D-0496-2026 | B Braun Medical Inc | 70% · Injection | 2026-04-29 |
Reading this record
Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. A search on event 98815 returns all 2 of these recall numbers; a search on D-0492-2026 returns only this configuration. Match a package against 0065-8064-01 at the FDA source to confirm it is covered.
Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Alcon Research LLC (2 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0492-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0492-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-05-06
- Ingested
- 2026-08-22
- Record hash
27caf692835dac51
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.